Received Oct 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U8313AA | IM / RL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y008289 | SC / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z003767 | SC / RL |
Patient's mother reports that patient did not previously have eczema, but developed severe eczema within one week of receiving the above vaccines. Eczema has persistent since this began and was assessed to be moderate severity at recent visit. Rash did not start near vaccine site, but patient's mother asserts that he did not have any rashes prior to receiving these vaccines. VAERS report filed due to reported temporal association of symptoms with first MMR and Varicella vaccines.
None
None
None
None
N/A